129 related articles for article (PubMed ID: 22635229)
1. The relationship between TORCH complex false positivity and obstetric outcome in patients with antiphospholipid syndrome.
De Carolis S; Santucci S; Botta A; Salvi S; Degennaro VA; Garufi C; Garofalo S; Ferrazzani S; Scambia G
Lupus; 2012 Jun; 21(7):773-5. PubMed ID: 22635229
[TBL] [Abstract][Full Text] [Related]
2. Association between false-positive TORCH and antiphospholipid antibodies in healthy pregnant women.
De Carolis S; Tabacco S; Rizzo F; Perrone G; Garufi C; Botta A; Salvi S; Benedetti Panici P; Lanzone A
Lupus; 2018 Apr; 27(5):841-846. PubMed ID: 29157179
[TBL] [Abstract][Full Text] [Related]
3. False-positive IgM for CMV in pregnant women with autoimmune disease: a novel prognostic factor for poor pregnancy outcome.
De Carolis S; Santucci S; Botta A; Garofalo S; Martino C; Perrelli A; Salvi S; Degennaro V; de Belvis A; Ferrazzani S; Scambia G
Lupus; 2010 Jun; 19(7):844-9. PubMed ID: 20305050
[TBL] [Abstract][Full Text] [Related]
4. Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy.
Ruffatti A; Tonello M; Cavazzana A; Bagatella P; Pengo V
Thromb Res; 2009; 123(3):482-7. PubMed ID: 18462781
[TBL] [Abstract][Full Text] [Related]
5. [Detection the serum IgM and IgG specific for TORCH in 1307 women in the period of pre-pregnancy and pregnancy].
Qin W; Hu DC; Pang HL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Aug; 25(4):292-4. PubMed ID: 22097611
[TBL] [Abstract][Full Text] [Related]
6. Laboratory and clinical features of pregnant women with antiphospholipid syndrome and neonatal outcome.
Ruffatti A; Calligaro A; Hoxha A; Trevisanuto D; Ruffatti AT; Gervasi MT; Cuffaro S; Pengo V; Punzi L
Arthritis Care Res (Hoboken); 2010 Mar; 62(3):302-7. PubMed ID: 20391475
[TBL] [Abstract][Full Text] [Related]
7. [Study on the relationship between the history of abnormal pregnancy and TORCH infection in pregnant woman].
Cao Y; Qiu L; Zhang Q
Zhonghua Fu Chan Ke Za Zhi; 1999 Sep; 34(9):517-20. PubMed ID: 11360633
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of torch infections and its associated poor outcome in high-risk pregnant women of Central India: Time to think for prevention strategies.
Manjunathachar HV; Singh KN; Chouksey V; Kumar R; Sharma RK; Barde PV
Indian J Med Microbiol; 2020; 38(3 & 4):379-384. PubMed ID: 33154250
[TBL] [Abstract][Full Text] [Related]
9. [Correlation between TORCH infections and abnormal pregnant outcomes].
Zhang QQ; Cheng JZ; Wang FH
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2013 Apr; 25(2):209-10. PubMed ID: 23894850
[TBL] [Abstract][Full Text] [Related]
10. Antiphospholipid syndrome: An update on risk factors for pregnancy outcome.
De Carolis S; Tabacco S; Rizzo F; Giannini A; Botta A; Salvi S; Garufi C; Benedetti Panici P; Lanzone A
Autoimmun Rev; 2018 Oct; 17(10):956-966. PubMed ID: 30118899
[TBL] [Abstract][Full Text] [Related]
11. Complementemia and obstetric outcome in pregnancy with antiphospholipid syndrome.
De Carolis S; Botta A; Santucci S; Salvi S; Moresi S; Di Pasquo E; Del Sordo G; Martino C
Lupus; 2012 Jun; 21(7):776-8. PubMed ID: 22635230
[TBL] [Abstract][Full Text] [Related]
12. Improvement of cytomegalovirus avidity testing by adjusting the concentration of CMV-specific IgG in test samples.
Dangel V; Bäder U; Enders G
J Clin Virol; 2006 Mar; 35(3):303-9. PubMed ID: 16298547
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal study of antinuclear and anticardiolipin antibodies in pregnant women with systemic lupus erythematosus and antiphospholipid syndrome.
Salazar-Páramo M; Jara LJ; Ramos A; Barile L; Machado G; García-De La Torre I
Rheumatol Int; 2002 Aug; 22(4):142-7. PubMed ID: 12172952
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune antibodies and pregnancy outcome in women with false-positive syphilis test results. A retrospective controlled investigation of women from 5170 deliveries.
Henriksen R; Sögaard PE; Grennert L; Hansen BU; Manthorpe R; Nilsson IM
Acta Obstet Gynecol Scand; 1989; 68(6):537-40. PubMed ID: 2520810
[TBL] [Abstract][Full Text] [Related]
15. TORCH serologies and specific IgM antibody determination in acquired and congenital infections.
Fung JC; Tilton RC
Ann Clin Lab Sci; 1985; 15(3):204-11. PubMed ID: 2986514
[TBL] [Abstract][Full Text] [Related]
16. [Usefulness of determining low-avidity IgG antibodies in the diagnosis of primary rubella infection in pregnant women].
Lafarga B; Noguera FJ; Pérez MC; Copado R; García A; Soria E
Enferm Infecc Microbiol Clin; 1998 Nov; 16(9):413-8. PubMed ID: 9887628
[TBL] [Abstract][Full Text] [Related]
17. Seasonal influence on TORCH infection and analysis of multi-positive samples with indirect immunofluorescence assay.
Chen L; Liu J; Shi L; Song Y; Song Y; Gao Y; Dong Y; Li L; Shen M; Zhai Y; Cao Z
J Clin Lab Anal; 2019 May; 33(4):e22828. PubMed ID: 30666721
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of toxoplasmosis, rubella, cytomegalovirus, and herpes (TORCH) infections among women attending the antenatal care clinic, maternity hospital in Abha, Southwestern Saudi Arabia.
Al-Hakami AM; Paul E; Al-Abed F; Alzoani AA; Shati AA; Assiri MI; Qasim AA; Riaz F; Moosa RA; Chandramoorthy HC
Saudi Med J; 2020 Jul; 41(7):757-762. PubMed ID: 32601646
[TBL] [Abstract][Full Text] [Related]
19. Antiphosphatidylserine/prothrombin antibodies in primary antiphospholipid syndrome.
Hoxha A; Ruffatti A; Tonello M; Bontadi A; Salvan E; Banzato A; Pengo V; Punzi L
Lupus; 2012 Jun; 21(7):787-9. PubMed ID: 22635234
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence, incidence of prenatal infections and reliability of maternal history of varicella zoster virus, cytomegalovirus, herpes simplex virus and parvovirus B19 infection in South-Western Finland.
Alanen A; Kahala K; Vahlberg T; Koskela P; Vainionpää R
BJOG; 2005 Jan; 112(1):50-6. PubMed ID: 15663397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
